Income Statement Mitsui Chemicals, Inc.

Equities

4183

JP3888300005

Commodity Chemicals

Delayed Japan Exchange Other stock markets 11:51:04 2026-01-14 pm EST			5-day change	1st Jan Change
2,105.00 ^JPY	+1.06%		+1.25%	+5.12%

Jan. 14	Vietnam's Nghi Son refinery processes first batch of non-Kuwaiti crude oil	RE
Dec. 23	Sumitomo Chemical to Fold Japan Polyolefin Units Into Prime Polymer JV	MT

9948592df1bb.60UEeEDNjRsfFqnI5PwEF1Jp1Hv5ruY5WS6Z1W7Qu1Q.pjBLNxT8_V9LJf6wkKhPRAE4mwzM15dJbEOq7V7n1GGEBlYsFoG_aV1M5A

Published financial data: MITSUI CHEMICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1,212B	1,613B	1,880B	1,750B	1,809B
Total Revenues	1,212B	1,613B	1,880B	1,750B	1,809B
Cost of Goods Sold, Total	918B	1,234B	1,498B	1,379B	1,421B
Gross Profit	294B	379B	381B	371B	388B
Selling General & Admin Expenses, Total	166B	188B	226B	221B	232B
Provision for Bad Debts	2.56B	7.31B	7.79B	2.77B	-214M
R&D Expenses	33.8B	38.12B	42.95B	44.7B	45.78B
Depreciation & Amortization - (IS)	12.5B	12.95B	15.92B	17.19B	17.78B
Other Operating Expenses	-1.83B	-690M	-1.61B	-525M	-380M
Other Operating Expenses, Total	213B	246B	291B	285B	295B
Operating Income	81.13B	133B	90.73B	85.9B	93.53B
Interest Expense, Total	-4.81B	-4.08B	-6.08B	-7.87B	-8.52B
Interest And Investment Income	2.15B	2.46B	5.01B	6.31B	7.24B
Net Interest Expenses	-2.66B	-1.63B	-1.07B	-1.55B	-1.28B
Income (Loss) On Equity Invest.	5.99B	25.82B	21.69B	12.3B	12.43B
Currency Exchange Gains (Loss)	-	-	-	6.92B	-3.39B
Other Non Operating Income (Expenses)	1.75B	3.28B	-2.59B	-3.08B	-1.91B
EBT, Excl. Unusual Items	86.2B	160B	109B	100B	99.38B
Impairment of Goodwill	-	7.25B	-	939M	-
Gain (Loss) On Sale Of Investments	-3M	-4.98B	23.12B	2.23B	-
Gain (Loss) On Sale Of Assets	-3.39B	-5.05B	-7.14B	-6.17B	-9.22B
Asset Writedown	-8.05B	-16.18B	-7.46B	-24.16B	-18.52B
Other Unusual Items	-515M	-1M	-14M	-	-
EBT, Incl. Unusual Items	74.24B	141B	117B	73.33B	71.65B
Income Tax Expense	10.02B	22.72B	27.14B	19.56B	29.02B
Earnings From Continuing Operations	64.22B	119B	90.14B	53.78B	42.63B
Net Income to Company	64.22B	119B	90.14B	53.78B	42.63B
Minority Interest	-6.35B	-8.56B	-7.2B	-3.78B	-10.39B
Net Income - (IS)	57.87B	110B	82.94B	50B	32.24B
Net Income to Common Incl Extra Items	57.87B	110B	82.94B	50B	32.24B
Net Income to Common Excl. Extra Items	57.87B	110B	82.94B	50B	32.24B
Per Share Items
Net EPS - Basic	149	282.73	215.59	131.49	85.28
Basic EPS - Continuing Operations	149	282.73	215.59	131.49	85.28
Basic Weighted Average Shares Outstanding	388M	389M	385M	380M	378M
Net EPS - Diluted	149	282.73	215.59	131.49	85.28
Diluted EPS - Continuing Operations	149	282.73	215.59	131.49	85.28
Diluted Weighted Average Shares Outstanding	388M	389M	385M	380M	378M
Normalized Basic EPS	122.37	235.43	157.97	155.24	136.82
Normalized Diluted EPS	122.37	235.43	157.97	155.24	136.82
Dividend Per Share	50	57.5	60	70	75
Payout Ratio	33.43	18.66	29.13	49.43	85.52
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	158B	217B	183B	181B	193B
EBITA	81.13B	133B	90.73B	85.9B	93.53B
EBIT	81.13B	133B	90.73B	85.9B	93.53B
Effective Tax Rate - (Ratio)	13.5	16.08	23.14	26.67	40.5
Normalized Net Income	47.53B	91.59B	60.77B	59.03B	51.73B
Interest Capitalized	-	50M	83M	323M	107M
Non-Cash Pension Expense	932M	692M	938M	345M	745M
Supplemental Operating Expense Items
Selling and Marketing Expenses	58.16B	68.64B	77.34B	71.66B	77.74B
Research And Development Expense From Footnotes	33.8B	38.1B	43B	44.7B	45.8B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	196B	181B	186B	210B	171B
Total Cash And Short Term Investments	196B	181B	186B	210B	171B
Accounts Receivable, Total	286B	370B	352B	366B	349B
Other Receivables	2.31B	13.21B	17.56B	15.48B	14.62B
Total Receivables	288B	384B	370B	381B	364B
Inventory	259B	369B	442B	451B	443B
Prepaid Expenses	5.04B	5.96B	6.27B	6.2B	7.37B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	39.58B	93.69B	90.01B	102B	56.32B
Total Current Assets	788B	1,033B	1,094B	1,151B	1,041B
Net Property Plant And Equipment	502B	554B	601B	652B	669B
Long-term Investments	238B	276B	295B	332B	351B
Goodwill	1.12B	17.98B	19.34B	21.17B	21.12B
Other Intangibles, Total	19.68B	45.34B	48.14B	55.24B	66.2B
Deferred Tax Assets Long-Term	9.33B	8.58B	10.27B	5.04B	5.08B
Total Assets	1,558B	1,935B	2,068B	2,216B	2,154B
Liabilities
Accounts Payable, Total	120B	175B	164B	180B	158B
Accrued Expenses, Total	-	-	-	-	-
Short-term Borrowings	162B	297B	324B	290B	235B
Current Portion of Long-Term Debt	54.54B	49.18B	44.34B	34.46B	47.7B
Current Income Taxes Payable	6.2B	12.9B	7.42B	4.04B	6.11B
Other Current Liabilities	123B	172B	155B	153B	157B
Total Current Liabilities	466B	707B	695B	661B	604B
Long-Term Debt	293B	319B	370B	433B	455B
Long-Term Leases	-	-	-	-	-
Pension & Other Post Retirement Benefits	16.38B	18.86B	20.24B	17.88B	16.94B
Deferred Tax Liability Non Current	27.83B	28.13B	35.16B	42.14B	44.71B
Other Non Current Liabilities	72.49B	54.81B	64.27B	77.11B	62.42B
Total Liabilities	876B	1,128B	1,185B	1,231B	1,183B
Common Stock, Total	125B	125B	126B	126B	126B
Additional Paid In Capital	74.01B	69.87B	57.78B	55.03B	55.08B
Retained Earnings	424B	516B	575B	617B	618B
Treasury Stock	-24.9B	-34.93B	-32.7B	-32.75B	-42.65B
Comprehensive Income and Other	9.4B	36.21B	61.06B	97.44B	91.81B
Total Common Equity	608B	713B	787B	863B	848B
Minority Interest	74.24B	94.47B	96.48B	122B	122B
Total Equity	682B	807B	883B	985B	971B
Total Liabilities And Equity	1,558B	1,935B	2,068B	2,216B	2,154B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	392M	386M	380M	380M	375M
ECS Total Common Shares Outstanding	392M	386M	380M	380M	375M
Book Value / Share	1.55K	1.84K	2.07K	2.27K	2.26K
Tangible Book Value	587B	649B	719B	786B	761B
Tangible Book Value Per Share	1.5K	1.68K	1.89K	2.07K	2.03K
Total Debt	510B	666B	738B	757B	738B
Net Debt	314B	485B	552B	546B	567B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-38.68B	-41.89B	-40.79B	-64.9B	-44.57B
Minority Interest, Total (Incl. Fin. Div)	74.24B	94.47B	96.48B	122B	122B
Equity Method Investments, Total	97.51B	133B	149B	156B	168B
Inventories - Raw Materials, Total	82.82B	116B	132B	132B	128B
Inventories - Work In Process, Total	7.48B	9.41B	11.67B	10.47B	10.92B
Inventories - Finished Goods, Total	169B	244B	298B	308B	304B
Full Time Employees	18.05K	18.78K	18.93K	19.86K	17.32K
Accumulated Allowance for Doubtful Accounts (Supple)	1.46B	1.26B	1.19B	1.12B	781M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	74.24B	141B	117B	73.33B	71.65B
Depreciation & Amortization - CF	76.62B	84.22B	92.08B	95.25B	99.77B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	76.62B	84.22B	92.08B	95.25B	99.77B
(Gain) Loss From Sale Of Asset	8.05B	16.18B	7.46B	24.16B	18.52B
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-5.99B	-25.82B	-21.69B	-12.3B	-12.43B
Other Operating Activities, Total	-1.98B	-7.15B	-23.47B	-12.02B	-7.82B
Change In Accounts Receivable	-7.11B	-62.94B	21.41B	-19.22B	23.33B
Change In Inventories	27.36B	-81.58B	-68.72B	-730M	5.55B
Change In Accounts Payable	-5.42B	39.97B	-11.02B	10.4B	-20.22B
Change in Other Net Operating Assets	8.55B	-11.57B	-12.08B	2.48B	22.16B
Cash from Operations	174B	92.58B	101B	161B	201B
Capital Expenditure	-74.9B	-107B	-132B	-144B	-121B
Sale of Property, Plant, and Equipment	591M	1.59B	490M	526M	284M
Cash Acquisitions	-6.18B	-87.91B	-3.72B	2.07B	-
Divestitures	99M	3.8B	-1.88B	38.73B	10.22B
Sale (Purchase) of Intangible assets	-1.59B	-9.14B	-5.51B	-9.91B	-17.19B
Investment in Marketable and Equity Securities, Total	4.28B	429M	36.24B	-1.04B	-35.94B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	150M	-6.93B	388M	-10.26B	-1.17B
Cash from Investing	-77.56B	-205B	-106B	-124B	-165B
Short Term Debt Issued, Total	-	125B	24.06B	3B	28.07B
Long-Term Debt Issued, Total	34.54B	75.29B	94.35B	96.83B	71.47B
Total Debt Issued	34.54B	200B	118B	99.83B	99.54B
Short Term Debt Repaid, Total	-18.5B	-	-	-41.68B	-82B
Long-Term Debt Repaid, Total	-53.39B	-56B	-49.04B	-44.48B	-34.94B
Total Debt Repaid	-71.89B	-56B	-49.04B	-86.16B	-117B
Issuance of Common Stock	3M	6M	5M	3M	4M
Repurchase of Common Stock	-691M	-10.04B	-10.02B	-49M	-10.03B
Common Dividends Paid	-19.35B	-20.53B	-24.16B	-24.71B	-27.57B
Common & Preferred Stock Dividends Paid	-19.35B	-20.53B	-24.16B	-24.71B	-27.57B
Other Financing Activities, Total	-11.57B	-24.51B	-32.65B	-14.92B	-19.44B
Cash from Financing	-68.96B	89.22B	2.54B	-26.02B	-74.44B
Foreign Exchange Rate Adjustments	3.6B	8.59B	7.72B	12.6B	-729M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	31.42B	-14.84B	5.16B	23.98B	-39.68B
Supplemental Items
Cash Interest Paid	4.7B	3.97B	5.89B	7.45B	8.02B
Cash Income Tax Paid (Refund)	7.76B	17.04B	34.39B	23.3B	18.11B
Levered Free Cash Flow	77.43B	-101B	-81.52B	-32.12B	68.39B
Unlevered Free Cash Flow	80.44B	-98.81B	-77.72B	-27.21B	73.72B
Change In Net Working Capital	-29.61B	150B	88.66B	22.16B	-53.9B
Net Debt Issued / Repaid	-37.34B	144B	69.37B	13.67B	-17.4B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.34	4.75	2.83	2.51	2.68
Return on Total Capital	4.31	6.23	3.66	3.19	3.39
Return On Equity %	9.96	15.92	10.66	5.76	4.36
Return on Common Equity	10.19	16.66	11.06	6.06	3.77
Margin Analysis
Gross Profit Margin %	24.25	23.48	20.3	21.19	21.46
SG&A Margin	13.67	11.68	12.01	12.62	12.81
EBITDA Margin %	13.02	13.45	9.73	10.35	10.68
EBITA Margin %	6.7	8.23	4.83	4.91	5.17
EBIT Margin %	6.7	8.23	4.83	4.91	5.17
Income From Continuing Operations Margin %	5.3	7.35	4.8	3.07	2.36
Net Income Margin %	4.78	6.82	4.41	2.86	1.78
Net Avail. For Common Margin %	4.78	6.82	4.41	2.86	1.78
Normalized Net Income Margin	3.92	5.68	3.23	3.37	2.86
Levered Free Cash Flow Margin	6.39	-6.29	-4.34	-1.84	3.78
Unlevered Free Cash Flow Margin	6.64	-6.13	-4.14	-1.55	4.07
Asset Turnover
Asset Turnover	0.8	0.92	0.94	0.82	0.83
Fixed Assets Turnover	2.45	3.06	3.26	2.79	2.74
Receivables Turnover (Average Receivables)	4.35	4.91	5.2	4.87	5.06
Inventory Turnover (Average Inventory)	3.36	3.93	3.69	3.09	3.18
Short Term Liquidity
Current Ratio	1.69	1.46	1.57	1.74	1.72
Quick Ratio	1.04	0.8	0.8	0.89	0.89
Operating Cash Flow to Current Liabilities	0.37	0.13	0.15	0.24	0.33
Days Sales Outstanding (Average Receivables)	83.99	74.27	70.16	75.1	72.16
Days Outstanding Inventory (Average Inventory)	108.72	92.85	98.79	118.51	114.81
Average Days Payable Outstanding	50.96	39.99	39.39	45.38	43.63
Cash Conversion Cycle (Average Days)	141.75	127.13	129.56	148.23	143.34
Long Term Solvency
Total Debt/Equity	74.79	82.53	83.58	76.84	76.03
Total Debt / Total Capital	42.79	45.21	45.53	43.45	43.19
LT Debt/Equity	43.02	39.58	41.86	43.93	46.93
Long-Term Debt / Total Capital	24.61	21.69	22.8	24.84	26.66
Total Liabilities / Total Assets	56.22	58.29	57.29	55.56	54.94
EBIT / Interest Expense	16.86	32.52	14.93	10.92	10.98
EBITDA / Interest Expense	32.79	53.14	30.08	23.03	22.7
(EBITDA - Capex) / Interest Expense	17.22	26.92	8.3	4.71	8.47
Total Debt / EBITDA	3.23	3.07	4.04	4.18	3.82
Net Debt / EBITDA	1.99	2.23	3.02	3.02	2.94
Total Debt / (EBITDA - Capex)	6.16	6.06	14.63	20.41	10.24
Net Debt / (EBITDA - Capex)	3.79	4.41	10.94	14.74	7.87
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-9.5	33.09	16.55	-6.91	3.4
Gross Profit, 1 Yr. Growth %	-1.11	28.89	0.73	-2.8	4.72
EBITDA, 1 Yr. Growth %	30.33	37.55	-15.75	-0.91	6.71
EBITA, 1 Yr. Growth %	16.61	63.65	-31.66	-5.33	8.89
EBIT, 1 Yr. Growth %	17.7	63.65	-31.66	-5.33	8.89
Earnings From Cont. Operations, 1 Yr. Growth %	38.73	84.6	-23.97	-40.34	-20.73
Net Income, 1 Yr. Growth %	52.52	90.05	-24.6	-39.71	-35.51
Normalized Net Income, 1 Yr. Growth %	45.79	92.69	-33.65	-2.87	-12.36
Diluted EPS Before Extra, 1 Yr. Growth %	52.87	89.75	-23.75	-39.01	-35.14
Accounts Receivable, 1 Yr. Growth %	5.16	29.59	-4.93	3.89	-4.49
Inventory, 1 Yr. Growth %	-10.14	42.58	19.77	2.06	-1.84
Net Property, Plant and Equip., 1 Yr. Growth %	3.38	10.28	8.54	8.52	2.63
Total Assets, 1 Yr. Growth %	5.27	24.19	6.89	7.14	-2.79
Tangible Book Value, 1 Yr. Growth %	17.74	10.6	10.78	9.33	-3.24
Common Equity, 1 Yr. Growth %	15.23	17.23	10.41	9.66	-1.69
Cash From Operations, 1 Yr. Growth %	51.62	-46.89	9.35	59.36	24.27
Capital Expenditures, 1 Yr. Growth %	4.18	42.94	23.61	8.86	-15.86
Levered Free Cash Flow, 1 Yr. Growth %	271.44	-230.9	-19.57	-60.6	-312.92
Unlevered Free Cash Flow, 1 Yr. Growth %	231.24	-222.84	-21.34	-65	-370.95
Dividend Per Share, 1 Yr. Growth %	0	15	4.35	16.67	7.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-9.6	9.75	24.54	4.16	-1.89
Gross Profit, 2 Yr. CAGR %	-3.62	12.9	13.94	-1.05	0.89
EBITDA, 2 Yr. CAGR %	5.06	33.89	7.65	-8.63	2.83
EBITA, 2 Yr. CAGR %	-7.14	38.14	5.75	-19.56	1.53
EBIT, 2 Yr. CAGR %	-6.81	38.78	5.75	-19.56	1.53
Earnings From Cont. Operations, 2 Yr. CAGR %	-13.85	60.03	18.47	-32.65	-31.23
Net Income, 2 Yr. CAGR %	-12.8	70.26	19.71	-32.58	-37.65
Normalized Net Income, 2 Yr. CAGR %	-6.14	67.61	13.07	-19.72	-7.74
Diluted EPS Before Extra, 2 Yr. CAGR %	-12.09	70.32	20.29	-31.8	-37.11
Accounts Receivable, 2 Yr. CAGR %	-3.96	16.74	11	-0.61	-0.38
Inventory, 2 Yr. CAGR %	-7.41	13.19	30.67	10.56	0.09
Net Property, Plant and Equip., 2 Yr. CAGR %	6.44	6.78	9.41	8.53	5.53
Total Assets, 2 Yr. CAGR %	1.88	14.34	15.21	7.01	2.05
Tangible Book Value, 2 Yr. CAGR %	6	14.11	10.69	10.05	2.85
Common Equity, 2 Yr. CAGR %	4.95	16.22	13.77	10.03	3.83
Cash From Operations, 2 Yr. CAGR %	26.18	-10.26	-23.79	32.01	40.73
Capital Expenditures, 2 Yr. CAGR %	18.67	22.03	32.92	16	-4.3
Levered Free Cash Flow, 2 Yr. CAGR %	22.21	120.51	2.61	-43.71	-8.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.61	101.71	-1.7	-47.53	-2.61
Dividend Per Share, 2 Yr. CAGR %	0	7.24	9.54	10.34	11.8
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-3.02	2.84	11.97	13.03	3.91
Gross Profit, 3 Yr. CAGR %	-1.7	6.19	8.69	8.06	0.83
EBITDA, 3 Yr. CAGR %	1.89	14.93	14.73	4.72	-3.78
EBITA, 3 Yr. CAGR %	-8.04	12.17	9.25	1.92	-11.02
EBIT, 3 Yr. CAGR %	-7.8	12.43	9.59	1.92	-11.02
Earnings From Cont. Operations, 3 Yr. CAGR %	-6.68	11.07	24.88	-5.74	-28.89
Net Income, 3 Yr. CAGR %	-6.84	13.06	29.78	-4.76	-33.57
Normalized Net Income, 3 Yr. CAGR %	-8.2	19.29	23.07	7.49	-17.34
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.96	13.61	30.29	-4.08	-32.94
Accounts Receivable, 3 Yr. CAGR %	-2.27	6.13	9.02	8.58	-1.92
Inventory, 3 Yr. CAGR %	-1.92	6.92	15.34	20.34	6.26
Net Property, Plant and Equip., 3 Yr. CAGR %	5.06	7.71	7.36	9.11	6.53
Total Assets, 3 Yr. CAGR %	2.57	8.83	11.8	12.45	3.64
Tangible Book Value, 3 Yr. CAGR %	6.97	7.51	12.99	10.23	5.43
Common Equity, 3 Yr. CAGR %	5.95	8.89	14.25	12.38	5.98
Cash From Operations, 3 Yr. CAGR %	28.24	-5.44	-4.15	-2.55	29.38
Capital Expenditures, 3 Yr. CAGR %	14.74	26.26	22.56	24.36	4.22
Levered Free Cash Flow, 3 Yr. CAGR %	91.51	25.04	57.55	-25.42	-12.29
Unlevered Free Cash Flow, 3 Yr. CAGR %	77.24	21.35	47.37	-30.33	-9.3
Dividend Per Share, 3 Yr. CAGR %	3.57	4.77	6.27	11.87	9.26
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-2.05	5.87	7.19	3.36	6.2
Gross Profit, 5 Yr. CAGR %	1.38	5.27	4.28	3.23	5.5
EBITDA, 5 Yr. CAGR %	5.7	8.42	4.15	4.85	9.82
EBITA, 5 Yr. CAGR %	1.83	5.41	-2.75	-1.8	6.1
EBIT, 5 Yr. CAGR %	2.72	5.67	-2.6	-1.67	6.3
Earnings From Cont. Operations, 5 Yr. CAGR %	16.86	9.93	2.67	-9.07	-1.63
Net Income, 5 Yr. CAGR %	20.31	11.15	2.99	-8.06	-3.2
Normalized Net Income, 5 Yr. CAGR %	7.58	12.1	-0.22	1.82	9.67
Diluted EPS Before Extra, 5 Yr. CAGR %	21.03	11.78	3.77	-7.37	-2.64
Accounts Receivable, 5 Yr. CAGR %	3.17	6.44	2.84	3.38	5.15
Inventory, 5 Yr. CAGR %	1.46	8.31	10.01	8.36	8.98
Net Property, Plant and Equip., 5 Yr. CAGR %	3.96	6.22	6.78	8.04	6.63
Total Assets, 5 Yr. CAGR %	4.36	7.86	7.45	8.1	7.79
Tangible Book Value, 5 Yr. CAGR %	11.43	9.39	8.44	8.52	8.82
Common Equity, 5 Yr. CAGR %	9.74	9.65	9.01	9.35	9.96
Cash From Operations, 5 Yr. CAGR %	3.62	-1.62	4.14	8.06	11.76
Capital Expenditures, 5 Yr. CAGR %	13.34	22.05	21.69	22.05	11.01
Levered Free Cash Flow, 5 Yr. CAGR %	-11.19	18.26	49.21	-9.13	26.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	-11.03	15.82	40.01	-13.23	24.87
Dividend Per Share, 5 Yr. CAGR %	20.11	13.9	5.92	6.96	8.45